Wave Life Sciences Ltd. Ordinary Shares (WVE) is a publicly traded Healthcare sector company. As of September 22, 2026, WVE trades at $4.27 with a market cap of $857.16M and a P/E ratio of -3.51. WVE moved +0.24% today. Year to date, WVE is -74.97%; over the trailing twelve months it is -38.24%. Its 52-week range spans $4.20 to $21.73. Analyst consensus is strong buy with an average price target of $17.60. Rallies surfaces WVE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
WVE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. WVE recently traded at $4.27. Market cap is $857.16M. P/E ratio is -3.51. Revenue is $42.73M.
| Metric | Value |
|---|---|
| Price | $4.27 |
| Market Cap | $857.16M |
| P/E Ratio | -3.51 |
| EPS | $-1.21 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.73 |
| 52-Week Low | $4.20 |
| Volume | 12.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $42.73M |
| Net Income | $-204.38M |
| Gross Margin | 0.00% |
10 analysts cover WVE: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.60.